General Information of Drug (ID: DMG4JFY)

Drug Name
NANT
Indication
Disease Entry ICD 11 Status REF
Pancreatic cancer 2C10 Phase 1/2 [1]
Cross-matching ID
PubChem CID
656911
TTD ID
D0T4GG

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)